NSD1 and overgrowth syndrome: The introduction of NGS in the molecular diagnosis of human overgrowth syndromes allowed us to identify nine intragenic novel mutations in six different genes associated with OGID and to explain about 4% (9/239) of cases of this cohort (analyzed with NGS), which resulted in being negative for mutations in the NSD1 gene.